BFRI
Biofrontera IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$10.34M
P/E Ratio
—
EPS
$-0.98
Beta
0.91
52W High
$1.19
52W Low
$0.54
50-Day MA
$0.97
200-Day MA
$0.91
Dividend Yield
—
Profit Margin
-25.70%
Forward P/E
13.64
PEG Ratio
—
About Biofrontera Inc
Biofrontera Inc., a biopharmaceutical company, develops and supplies dermatological products for the treatment of skin conditions in the United States. The company is headquartered in Woburn, Massachusetts.
Fundamentals
| Revenue (TTM) | $43.20M |
| Gross Profit (TTM) | $33.39M |
| EBITDA | $-10.56M |
| Operating Margin | -39.00% |
| Return on Equity | -339.00% |
| Return on Assets | -32.40% |
| Revenue/Share (TTM) | $3.97 |
| Book Value | $0.52 |
| Price-to-Book | 1.70 |
| Price-to-Sales (TTM) | 0.24 |
| EV/Revenue | 0.272 |
| EV/EBITDA | -0.79 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 17.40% |
| Shares Outstanding | $12.80M |
| Float | $8.06M |
| % Insiders | 12.84% |
| % Institutions | 21.97% |
Historical Volatility
HV 10-Day
116.71%
HV 20-Day
90.59%
HV 30-Day
78.71%
HV 60-Day
70.23%
HV Rank
63.5%
Volatility is currently expanding
Analyst Ratings
Consensus ($5.88 target)
2
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026